Cite

HARVARD Citation

    Behrens, F. et al. (n.d.). SAT0182 Tocilizumab s.c. – improvement of the depressiveness, fatigue and pain in ra therapy. Annals of the rheumatic diseases. p. 952. [Online]. 
  
Back to record